// App-Quantinova.ai

P708 : CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY.

Researchers

Presenter

  • Fatima Khadadah

Principal Investigators

  • Elza Lomaia

  • Elena V. Morozova

  • Oleg A. Shukhov

  • Anna Petrova

  • Tamara Chitanava

  • Julia J. Vlasova

  • Irina Nemchenko

  • Ekaterina Yu. Chelysheva

  • Anastasiya Bykova

  • Margarita Gurianova

  • Anargyros Xenocostas

  • Lambert Busque

  • Kareem Jamani

  • Sonia Cerquozzi

  • Philip Kuruvilla

  • Rayan Kaedbey

  • Brian Leber

  • Sarit Assouline

  • Dennis Dong Hwan Kim

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Juravincki Cancer Centre,Hamilton,Canada

  • Jewish General Hospital, Montreal, QC, Canada

  • National Medical Research Center for Hematology,Moscow ,Р

  • Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

  • Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

  • Juravinski Cancer Center, Hamilton, Ontario, Canada.

  • William Osler Health System,Brampton,Канада

  • Maisonneuve-Rosemont Hospital,Mo

  • William Osler Health System, Brampton,Canada

  • Jewish General Hospital, Montreal, QC, Canada

  • Maisonneuve-Rosemont Hospital,Montreal,Канада

  • Juravincki Cancer Centre,Hamilton,Canada

  • National Research Center for Hematology, Moscow, Russia

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Princess Margaret Cancer Centre,Toronto,Канада

  • . Raisa

  • London Health Sciences Centre, Victoria Hospital, London, Ontario, Canada

  • Jewish General Hospital,Montreal,Канада

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • London Health Sciences

  • . Raisa Gorbacheva Memorial Research Institute of Children's Oncology, Hematology and Transplantation,Saint-Petersburg,Russia

  • Juravinski Cancer Center,Hamilton,Канада

  • Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

  • Almazov National Medical Research Centre, Saint‐Petersburg, Russian Federation

  • William Osler Health System, Brampton,Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Almazov National Medical Research Centre, Saint‐Petersburg, Russian Federation

  • Tom Baker Cancer Centre,Calgary,Канада

  • . Raisa Gorbacheva Memorial Research Institute of Children's Oncology, Hematology and Transplantation,Saint-Petersburg,Russia

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Princess Margaret Cancer Centre,...

  • . Raisa Gorbacheva Memorial Research Institute of Children's Oncology, Hematology and Transplantation,Saint-Petersburg,Russia

  • William Osler Health System, Brampton,Canada

  • Jewish General Hospital, Montreal, QC, Canada

  • Almazov National Medical Research Centre, Saint‐Petersburg, Russian Federation

  • National Research Center for Hematology, Moscow, Russia

  • Almazov National Medical Research Centre, Saint‐Petersburg, Russian Federation

  • . Raisa Gorbacheva Memorial Research Institute of Children's Oncology, Hematology and Transplantation,Saint-Petersburg,Russia

  • Raisa Gorbach

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • National Research Center for Hematology, Moscow, Russia

  • London Health Sciences Centre, Victoria Hospital, London, Ontario, Canada

  • 4Almazov National Medical Research Centre

  • National Research Center for Hematology, Moscow, Russia

  • London Health Sciences Centre, Victoria Hospital, London, Ontario, Canada

Locations

  • Canada

  • United States

  • Russia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 206

Drug/Treatment

  • Bosutinib

  • Nilotinib

  • Ponatinib

  • dasatinib

  • ABL001

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved